Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. J.E. (Jorine) Hartman


Treatable traits in advanced emphysema patients eligible for bronchoscopic lung volume reduction with endobronchial valves

A bronchial gene signature specific for severe COPD that is retained in the nose

Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency

Bronchoscopic Lung Volume Reduction with Endobronchial Valves Exclusively of the Middle Lobe in Patients with Emphysema

Computed tomographic airway morphology after targeted lung denervation treatment in COPD

Impact of Endobronchial Valve Treatment on Lung Function Decline

Improved exercise capacity results in a survival benefit after endobronchial valve treatment

Prevalence and Impact of COVID-19 among Severe COPD Patients post Bronchoscopic Lung Volume Reduction Treatment with Endobronchial Valves

Response to endobronchial valve treatment: it's all about the target lobe

The impact of emphysema heterogeneity on treatment response after endobronchial valve treatment

Read more


Assessing the DIAphragM Before ANd After Endobronchial Valve Treatment (DIAMANT)